scholarly journals Hepatic mRNA expression for genes related to somatotropic axis, glucose and lipid metabolisms, and inflammatory response of periparturient dairy cows treated with recombinant bovine somatotropin

2017 ◽  
Vol 100 (5) ◽  
pp. 3983-3999 ◽  
Author(s):  
P.R.B. Silva ◽  
W.J. Weber ◽  
B.A. Crooker ◽  
R.J. Collier ◽  
W.W. Thatcher ◽  
...  
1999 ◽  
Vol 52 (3) ◽  
pp. 481-496 ◽  
Author(s):  
L.J. Judge ◽  
P.C. Bartlett ◽  
J.W. Lloyd ◽  
R.J. Erskine

2018 ◽  
Vol 3 (1) ◽  
pp. 443-455 ◽  
Author(s):  
Philipe Moriel ◽  
Bruno Ieda Cappellozza ◽  
Matheus B Piccolo ◽  
Reinaldo F Cooke ◽  
Miguel F Miranda ◽  
...  

Abstract The present study evaluated the growth and puberty attainment of Bos indicus heifers administered recombinant bovine somatotropin (bST) or saline injections during preweaning and/or postweaning. On day 0, 177 suckling Nellore heifers were stratified by initial age and body weight (BW) (80 ± 10 d; 97 ± 16 kg), and randomly assigned, in a 2 × 2 factorial design (n = 44 to 45 heifers/treatment), to receive s.c. injections of saline (5 mL 0.9% NaCl) or sometribove zinc (Posilac; Elanco, Greenfield, IN; 6.14 mg/kg of BW0.75) on days 0 and 10 (PRE) and/or days 167 and 177 (POS). All heifers were managed as a single group in Brachiaria decumbens pastures from day 0 until 24 d postweaning (day 191), and then provided a corn silage–based TMR from days 191 to 380 to achieve 65% to 70% of mature BW at the end of the study (day 380). Heifer full BW was collected on days 0, 10, 167, 177, and monthly from days 191 to 380. Transrectal ultrasonography of ovaries was performed on days 1 and 10 of each month from days 229 to 380 to assess the percentage of pubertal heifers. Liver biopsies and blood samples from jugular vein were collected on days 0, 10, 167, 177, and 380. Additional blood samples were collected monthly from days 259 to 380 (n = 10 to 15 heifers/treatment). No interactions among day of the study, PRE, and POS injections of saline or bST were detected (P ≥ 0.11). Preweaning bST injections increased heifer average daily gain (ADG) from days 0 to 10 and plasma IGF-1 on day 10 (P ≤ 0.03), did not affect ADG from days 0 to 177, plasma IGF-1 from days 259 to 380, and any liver gene mRNA expression (P ≥ 0.19), but tended to decrease ADG from days 191 to 380 (P = 0.07) and percentage of pubertal heifers on days 349 (P = 0.07), 359 (P = 0.002), and 380 (P = 0.0001) compared with saline injections. Postweaning bST injections increased plasma IGF-1 on day 177 and overall liver mRNA expression of GHR-1A (P ≤ 0.05), decreased plasma IGF-1 from days 259 to 380 (P = 0.03), tended to decrease liver mRNA expression of GHR-1B on day 177 (P = 0.08), but did not affect ADG from days 167 to 177 and 191 to 380, and puberty attainment from days 229 to 380 (P ≥ 0.12) compared with saline injections. Thus, preweaning and postweaning injections of bST successfully increased heifer plasma IGF-1 concentrations 10 d after first injection. Postweaning injections of bST had no impact on puberty attainment, whereas preweaning bST injections of bST impaired puberty attainment of Nellore beef heifers.


1990 ◽  
Vol 73 (10) ◽  
pp. 2907-2915 ◽  
Author(s):  
Richard A. Erdman ◽  
Bal K. Sharma ◽  
Randy D. Shaver ◽  
Ralph M. Cleale

1997 ◽  
Vol 80 (10) ◽  
pp. 2355-2360 ◽  
Author(s):  
J.T. Huber ◽  
Z. Wu ◽  
C. Fontes ◽  
J.L. Sullivan ◽  
R.G. Hoffman ◽  
...  

1991 ◽  
Vol 71 (2) ◽  
pp. 343-353 ◽  
Author(s):  
Guillermo F. Gallo ◽  
Elliot Block

Three trials were conducted to determine the effects of recombinant bovine somatotropin (rbST) on reproductive functions of lactating Holstein dairy cows. In Trial 1, 49 cows were used to investigate the effects of 0, 320 or 640 mg of rbST in a sustained-release formulation injected every 28 d on plasma progesterone (P4) concentration during estrous cycles. Total P4 area and P4 mean were increased (P < 0.05) in rbST-treated cows during the 1st and 2nd detected estrous cycle post-rbST injection. Maximum P4 value, slope of the P4 decline and length of cycles were not affected by rbST treatment. In Trial 2, 56 cows were used to investigate the effects of 0, 320, 640 and 960 mg of rbST in a sustained-release preparation injected every 28 d on plasma P4 concentration from weeks 1 to 34 of pregnancy. Mean P4 was increased (P = 0.08) in rbST-treated cows proportionally to the rbST dose received. In Trial 3, 18 cows were used to investigate the effects of 0 or 25 mg d−1 of rbST injected from days 3 to 15 postpartum (pp) on the gonadotropin-releasing hormone (GnRH) induced luteinizing hormone (LH) response curve at 14 d pp. Total area under the LH curve and LH peak value were increased (P < 0.05) in rbST-treated cows, but LH baseline and time to LH peak were not different among groups. Cows receiving rbST were in a more negative energy balance due to higher milk production. In summary, long-term administration of rbST increased the concentration of plasma progesterone during the first two estrous cycles post-treatment and during pregnancy, and enhanced the GnRH-induced LH response at 14 d pp. Key words: Bovine somatotropin, GnRH-LH induction, progesterone, estrous cycle, pregnancy


1990 ◽  
Vol 70 (2) ◽  
pp. 723-726 ◽  
Author(s):  
D. M. LEFEBVRE ◽  
G. F. GALLO ◽  
E. BLOCK

Serum cortisol levels were determined in 18 cows administered 25 mg d−1 of recombinant bovine somatotropin or a placebo following jugular vein catheterization on day 14 postpartum. Cows that received assistance at calving had lower (P < 0.01) serum cortisol concentration postpartum. Restraint and catheterization caused an elevation (P < 0.1) of cortisol levels. Treatment with rbST did not effect postpartum cortisol levels. LH response to exogenous GnRH was not affected by the postpartum Cortisol level. Key words: Cortisol, somatotropin, ganadotropin-releasing hormone, luteinizing hormone, dairy cow, stress


1990 ◽  
Vol 73 (1) ◽  
pp. 181-190 ◽  
Author(s):  
Helen W. Leitch ◽  
Edward B. Burnside ◽  
Brian W. McBride

Sign in / Sign up

Export Citation Format

Share Document